Lung cancer

Therapeutic modalities and cytoprotection

J. H. Schiller

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Lung cancer is the leading cancer killer in the United States today. The current methods of treatment, radiation and various chemotherapies, have been used with some success; however, early detection remains the key to successful therapy. Current clinical trials indicate that an improvement of available therapies is needed. Consequently, the development of new approaches to treatment is foremost in the minds of researchers. Advances in molecular medicine have produced new drugs that can protect normal cells from chemotherapy-induced toxicities, resulting in enhanced drug delivery with few dose reductions. This review will discuss some of the advances that have been made in understanding the molecular biology of lung cancer as well as the current and most promising methods of treatment used for various forms of lung cancer. The potential contribution of cytoprotectors to enhance the safety and effectiveness of these therapies will be examined.

Original languageEnglish (US)
Pages (from-to)145-164
Number of pages20
JournalLung
Volume176
Issue number3
DOIs
StatePublished - 1998

Fingerprint

Cytoprotection
Lung Neoplasms
Therapeutics
Molecular Medicine
Drug Therapy
Pharmaceutical Preparations
Molecular Biology
Research Personnel
Clinical Trials
Radiation
Safety
Neoplasms

Keywords

  • Chemotherapy
  • Cytoprotection
  • Lung cancer
  • Radiation therapy
  • Toxicity

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Physiology

Cite this

Lung cancer : Therapeutic modalities and cytoprotection. / Schiller, J. H.

In: Lung, Vol. 176, No. 3, 1998, p. 145-164.

Research output: Contribution to journalArticle

Schiller, J. H. / Lung cancer : Therapeutic modalities and cytoprotection. In: Lung. 1998 ; Vol. 176, No. 3. pp. 145-164.
@article{72b40997f994447496515d3c309ecd77,
title = "Lung cancer: Therapeutic modalities and cytoprotection",
abstract = "Lung cancer is the leading cancer killer in the United States today. The current methods of treatment, radiation and various chemotherapies, have been used with some success; however, early detection remains the key to successful therapy. Current clinical trials indicate that an improvement of available therapies is needed. Consequently, the development of new approaches to treatment is foremost in the minds of researchers. Advances in molecular medicine have produced new drugs that can protect normal cells from chemotherapy-induced toxicities, resulting in enhanced drug delivery with few dose reductions. This review will discuss some of the advances that have been made in understanding the molecular biology of lung cancer as well as the current and most promising methods of treatment used for various forms of lung cancer. The potential contribution of cytoprotectors to enhance the safety and effectiveness of these therapies will be examined.",
keywords = "Chemotherapy, Cytoprotection, Lung cancer, Radiation therapy, Toxicity",
author = "Schiller, {J. H.}",
year = "1998",
doi = "10.1007/PL00007599",
language = "English (US)",
volume = "176",
pages = "145--164",
journal = "Lung",
issn = "0341-2040",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Lung cancer

T2 - Therapeutic modalities and cytoprotection

AU - Schiller, J. H.

PY - 1998

Y1 - 1998

N2 - Lung cancer is the leading cancer killer in the United States today. The current methods of treatment, radiation and various chemotherapies, have been used with some success; however, early detection remains the key to successful therapy. Current clinical trials indicate that an improvement of available therapies is needed. Consequently, the development of new approaches to treatment is foremost in the minds of researchers. Advances in molecular medicine have produced new drugs that can protect normal cells from chemotherapy-induced toxicities, resulting in enhanced drug delivery with few dose reductions. This review will discuss some of the advances that have been made in understanding the molecular biology of lung cancer as well as the current and most promising methods of treatment used for various forms of lung cancer. The potential contribution of cytoprotectors to enhance the safety and effectiveness of these therapies will be examined.

AB - Lung cancer is the leading cancer killer in the United States today. The current methods of treatment, radiation and various chemotherapies, have been used with some success; however, early detection remains the key to successful therapy. Current clinical trials indicate that an improvement of available therapies is needed. Consequently, the development of new approaches to treatment is foremost in the minds of researchers. Advances in molecular medicine have produced new drugs that can protect normal cells from chemotherapy-induced toxicities, resulting in enhanced drug delivery with few dose reductions. This review will discuss some of the advances that have been made in understanding the molecular biology of lung cancer as well as the current and most promising methods of treatment used for various forms of lung cancer. The potential contribution of cytoprotectors to enhance the safety and effectiveness of these therapies will be examined.

KW - Chemotherapy

KW - Cytoprotection

KW - Lung cancer

KW - Radiation therapy

KW - Toxicity

UR - http://www.scopus.com/inward/record.url?scp=0031778345&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031778345&partnerID=8YFLogxK

U2 - 10.1007/PL00007599

DO - 10.1007/PL00007599

M3 - Article

VL - 176

SP - 145

EP - 164

JO - Lung

JF - Lung

SN - 0341-2040

IS - 3

ER -